Placement of Reveal LINQ Device in the Left Anterior Axillary Position.

Published on Jan 1, 2020in Pediatric Cardiology1.564
· DOI :10.1007/S00246-019-02242-9
Heather N. Anderson6
Estimated H-index: 6
(Mayo Clinic),
Joseph A. Dearani95
Estimated H-index: 95
(Mayo Clinic)
+ 4 AuthorsPhilip L. Wackel6
Estimated H-index: 6
(Mayo Clinic)
Sources
Abstract
Implantable loop recorders (ILR) are utilized for long-term rhythm monitoring. Typical placement of the Medtronic Reveal LINQ along the left parasternal border may compromise the quality and/or feasibility of future imaging studies. We sought to evaluate the utility of placing an ILR in the left anterior axillary position and the impact on the quality of cardiac imaging. We reviewed patients from May 2017 to June 2018 who had placement of a Reveal LINQ device in the left anterior axillary position. Demographic, procedural, and clinical data were collected via retrospective review. Cardiac magnetic resonance imaging (MRI) studies were reviewed for image quality after ILR placement. Eight patients met inclusion criteria for this study (median age 6 years, 50% female). Six patients (75%) had an ILR placed in the operating room, while all others were placed in the electrophysiology lab. All patients demonstrated acceptable R waves for diagnostic evaluation (median = 0.85 mV, range 0.24–1.7 mV). Cardiac MRI was obtained in 7 patients following ILR placement with diagnostic image quality and no adverse events. One device was explanted 28 days after placement due to concern for possible infection. No other devices required removal or revision (median follow up duration 11 months, IQR 8–13.5). ILR placement in the left anterior axillary position can record adequate signals in pediatric patients. In addition, axillary ILR device position may allow for completion of cardiac imaging, particularly cardiac MRI, without significant artifacts which is critical for patients with congenital heart disease.
📖 Papers frequently viewed together
7 Citations
40 Citations
9 Citations
References17
Newest
Objective:At our tertiary cardiothoracic centre, cardiac MRI and thoracic CT scans are performed in patients with implanted LINQ devices. The degree of foreign body artefact associated with the LINQ device, and its clinical importance, has not previously been assessed. A case series review was therefore performed with a simultaneous review of patient safety and data loss events, secondary to the MRI environment.Methods:A local database search identified LINQ device patients who underwent thoraci...
2 CitationsSource
#1Hoang H. Nguyen (WashU: Washington University in St. Louis)H-Index: 8
#2Ian H. Law (UI: University of Iowa)H-Index: 21
Last. Jennifer N.A. Silva (WashU: Washington University in St. Louis)H-Index: 13
view all 7 authors...
Objectives To compare the procedure, recovery, hospitalization times, and costs along with patient/parent satisfaction after newer-generation cardiac implantable loop recorder (Reveal LINQ; Medtronic Inc, Minneapolis, Minnesota) and previous-generation implantable loop recorder (Reveal XT; Medtronic Inc). Study design A prospective study of patients undergoing LINQ implantations between April 2014 and October 2015 was performed. Retrospective chart review of patients undergoing XT implantations ...
3 CitationsSource
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [#][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Kim K. Birtcher, MS, PharmD, AACC Biykem Bozkurt, MD, PhD, FACC, FAHA Ralph G. Brindis, MD, MPH,
341 CitationsSource
#1Roshan D'SouzaH-Index: 1
#2Elizabeth ThomasH-Index: 1
Last. Christopher S. SnyderH-Index: 17
view all 6 authors...
Implantable loop recorders are commonly used to sense arrhythmias. The purpose of this study is to assess the P- and R-wave amplitudes at implantation (I) and follow-up (F) following insertion of the Reveal LINQ™ Insertable Cardiac Monitor (Medtronic, Minneapolis, MN) in an institutional review board-approved, multicenter study performed on pediatric patients younger than 18 years old. Collected data included demographics, presence of congenital heart disease (CHD), P- and R-wave-sensed amplitud...
2 CitationsSource
#1Geoffrey R. Wong (Royal Adelaide Hospital)H-Index: 9
#2Dennis H. Lau (Royal Adelaide Hospital)H-Index: 55
Last. Prashanthan Sanders (Royal Adelaide Hospital)H-Index: 102
view all 12 authors...
Abstract Background Insertable cardiac monitors (ICMs) are increasingly utilized for diagnosis of unexplained syncope and arrhythmia monitoring. The Reveal LINQ is a novel miniaturized ICM with improved algorithms. The feasibility and safety of insertion outside the traditional electrophysiology laboratory is unknown. Here we compare outcomes of Reveal LINQ insertion in different environments. Methods We report on a prospective, single-centre, non-randomized, observational experience of consecut...
20 CitationsSource
#1Ahmad Sami Chaouki (Cincinnati Children's Hospital Medical Center)H-Index: 5
#2Richard J. Czosek (Cincinnati Children's Hospital Medical Center)H-Index: 19
Last. David S. Spar (University of Cincinnati Academic Health Center)H-Index: 9
view all 3 authors...
Cardiac rhythm monitoring has been facilitated by the use of implantable loop recorders. New models of these devices are 87% smaller than before allowing for easier implantation and use in the paediatric population. Recommendations are for closure with adhesive. We report a device extrusion in a 6-year-old patient. Based on this, our practice has changed to include subcutaneous sutures this complication.
6 CitationsSource
#1Lisa J. Hutchinson (Bristol Royal Hospital for Children)H-Index: 1
#2Graham Stuart (Bristol Royal Hospital for Children)H-Index: 11
Last. Mark A. Walsh (Bristol Royal Hospital for Children)H-Index: 5
view all 3 authors...
boy with tuberous sclerosis with frequentventricular arrhythmiassecondarytocardiacrhabdomyomas.Hewasdiagnosedat1weekofageandhad two cardiac arrests secondary to torsade de pointesinthepaediatricICUinhis firstcoupleofweeksoflife.Thereweretwolargecardiacrhabdomyomasintheleftventricle, one in the apex and one in the outflow tract.He developed a long QT interval secondary to anti-arrhythmic medications, but was eventually controlledon a β-blocker and mexiletine. He was discharged andspent 8 months at ...
12 CitationsSource
#1Sampath Gunda (KU: University of Kansas)H-Index: 15
#2Yeruva Madhu Reddy (KU: University of Kansas)H-Index: 14
Last. Dhanunjaya Lakkireddy (University of Kansas Hospital)H-Index: 49
view all 15 authors...
Abstract Introduction Limited data is available regarding the novel Reveal LinQ™ (LinQ) which is a new generation implantable loop recorders (ILRs). Methods We performed a prospective, observational study of all consecutive patients undergoing conventional (Reveal XT™; XT) and LinQ devices at our institution between January 2012 and December 2014. Results A total of 217 patients underwent ILR implantation. XT was implanted in 105 and LinQ in 112 patients. There were no significant differences in...
28 CitationsSource
#2Prashanthan Sanders (Royal Adelaide Hospital)H-Index: 102
Last. Lukas R.C. DekkerH-Index: 25
view all 6 authors...
Background The Reveal LINQ is a miniaturized insertable cardiac monitor (ICM) with wireless telemetry for remote monitoring of patients with suspected arrhythmias. Objective The primary objective of this study was to evaluate the functionality of the Reveal LINQ system by measuring R-wave sensing and data transmission. Methods The Reveal LINQ Usability Study was a nonrandomized, prospective, multicenter trial. The study enrolled 30 patients with any indication for an ICM. Data were collected at ...
64 CitationsSource
#1Yakup ErgülH-Index: 10
Last. Volkan TuzcuH-Index: 13
view all 5 authors...
Background Syncope is a frequent complaint in children and adolescents and may be a significant sign of serious pathology. Although patient history, family history, and physical examination are sufficient to reach a diagnosis in most cases of syncope, the cause of syncope still cannot be determined after initial investigation in one-third to half of all patients. The aim of this study was to evaluate the diagnostic yield of implantable loop recorder (ILR) in children with unexplained syncope. Me...
12 CitationsSource
Cited By1
Newest
#2Joseph A. Dearani (UR: University of Rochester)H-Index: 95
#5Bryan C. Cannon (UR: University of Rochester)H-Index: 29
Last. Karen Cavanaugh (Mayo Clinic)H-Index: 2
view all 13 authors...
Abstract Background The objective of this study is to assess the safety and early impact of intramyocardial delivery of autologous bone marrow-derived mononuclear cells (BM-MNC) at time of surgical Ebstein repair. Methods Patients with EA (ages 6 months to 30 years) scheduled to undergo repair of the TV were eligible to participate in this open label, non-randomized Phase I clinical trial. BM-MNC target dose was 1-3 million cells/kg. Ten patients have undergone surgical intervention and cell del...
2 CitationsSource